Author
Listed:
- Baojun Chang
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Kandice L. Tessneer
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- John McManus
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Xiaolei Liu
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
University of Oklahoma Health Sciences Center)
- Scott Hahn
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Satish Pasula
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Hao Wu
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Hoogeun Song
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Yiyuan Chen
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Xiaofeng Cai
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Yunzhou Dong
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Megan L. Brophy
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
University of Oklahoma Health Sciences Center)
- Ruby Rahman
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Jian-Xing Ma
(Harold Hamm Oklahoma Diabetes Center, University of Oklahoma Health Sciences Center)
- Lijun Xia
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
University of Oklahoma Health Sciences Center)
- Hong Chen
(Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
University of Oklahoma Health Sciences Center)
Abstract
Uncontrolled canonical Wnt signalling supports colon epithelial tumour expansion and malignant transformation. Understanding the regulatory mechanisms involved is crucial for elucidating the pathogenesis of and will provide new therapeutic targets for colon cancer. Epsins are ubiquitin-binding adaptor proteins upregulated in several human cancers; however, the involvement of epsins in colon cancer is unknown. Here we show that loss of intestinal epithelial epsins protects against colon cancer by significantly reducing the stability of the crucial Wnt signalling effector, dishevelled (Dvl2), and impairing Wnt signalling. Consistently, epsins and Dvl2 are correspondingly upregulated in colon cancer. Mechanistically, epsin binds Dvl2 via its epsin N-terminal homology domain and ubiquitin-interacting motifs and prohibits Dvl2 polyubiquitination and degradation. Our findings reveal an unconventional role for epsins in stabilizing Dvl2 and potentiating Wnt signalling in colon cancer cells to ensure robust colon cancer progression. The pro-carcinogenic role of Epsins suggests that they are potential therapeutic targets to combat colon cancer.
Suggested Citation
Baojun Chang & Kandice L. Tessneer & John McManus & Xiaolei Liu & Scott Hahn & Satish Pasula & Hao Wu & Hoogeun Song & Yiyuan Chen & Xiaofeng Cai & Yunzhou Dong & Megan L. Brophy & Ruby Rahman & Jian-, 2015.
"Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development,"
Nature Communications, Nature, vol. 6(1), pages 1-17, May.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7380
DOI: 10.1038/ncomms7380
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7380. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.